Arcadia Biosciences Stockholders Back Directors and Governance Moves
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Arcadia Biosciences ( (RKDA) ) has issued an update.
At its annual meeting of stockholders held on December 19, 2025, Arcadia Biosciences reported that holders of approximately 51% of its outstanding common shares were present in person or by proxy, providing the quorum needed to conduct business. Stockholders elected three Class I directors, Albert Bolles, Kevin Comcowich and Thomas J. Schaefer, to serve until the 2028 annual meeting, approved on an advisory basis the compensation of the company’s named executive officers, and ratified the appointment of Deloitte & Touche LLP as Arcadia’s independent registered public accountants for the fiscal year ending December 31, 2025, signaling continued shareholder support for the company’s leadership, governance structure and financial oversight.
The most recent analyst rating on (RKDA) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Arcadia Biosciences stock, see the RKDA Stock Forecast page.
Spark’s Take on RKDA Stock
According to Spark, TipRanks’ AI Analyst, RKDA is a Neutral.
Arcadia Biosciences faces significant financial challenges, with declining revenue and ongoing unprofitability, which heavily impacts its overall score. Technical indicators provide a mixed outlook, with some potential for bullish momentum but no strong trend. The valuation is unattractive due to a negative P/E ratio and lack of dividends. These factors combine to result in a moderate overall stock score.
To see Spark’s full report on RKDA stock, click here.
More about Arcadia Biosciences
Arcadia Biosciences, Inc. operates in the agricultural and food technology sector, focusing on developing and commercializing crop innovations and related bioscience solutions aimed at improving crop quality, sustainability, and nutritional profiles for consumer and industrial markets.
Average Trading Volume: 536,369
Technical Sentiment Signal: Sell
Current Market Cap: $5.07M
For an in-depth examination of RKDA stock, go to TipRanks’ Overview page.
